Barbara Meissner

8.2k total citations
47 papers, 1.8k citations indexed

About

Barbara Meissner is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Barbara Meissner has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 11 papers in Genetics and 11 papers in Oncology. Recurrent topics in Barbara Meissner's work include Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). Barbara Meissner is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). Barbara Meissner collaborates with scholars based in Canada, Germany and United States. Barbara Meissner's co-authors include Marco A. Marra, Randy D. Gascoyne, Merrill Boyle, Ryan D. Morin, Andrew J. Mungall, Hannelore Daniel, Ralf Baumeister, Michael Boll, Christian Steidl and Susana Ben‐Neriah and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Barbara Meissner

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Meissner Canada	20	797	562	456	310	308	47	1.8k
Elizabeth A. Chavez Canada	24	1.9k 2.3×	297 0.5×	412 0.9×	188 0.6×	56 0.2×	41	2.9k
Christopher C. Oakes United States	27	1.7k 2.2×	281 0.5×	252 0.6×	410 1.3×	276 0.9×	67	2.5k
Fritz Lampert Germany	20	787 1.0×	124 0.2×	237 0.5×	139 0.4×	546 1.8×	52	1.8k
Mary Callanan France	22	957 1.2×	395 0.7×	431 0.9×	307 1.0×	190 0.6×	67	1.9k
Thomas Trimarchi United States	17	1.4k 1.8×	88 0.2×	392 0.9×	126 0.4×	394 1.3×	20	2.0k
Samuel Y. Ng United States	12	571 0.7×	183 0.3×	206 0.5×	147 0.5×	267 0.9×	19	1.1k
Misao Ohki Japan	19	2.3k 2.9×	69 0.1×	365 0.8×	114 0.4×	633 2.1×	26	2.9k
Srinivas R. Viswanathan United States	13	2.3k 2.9×	52 0.1×	149 0.3×	152 0.5×	185 0.6×	26	3.1k
Renate Kirschner‐Schwabe Germany	19	937 1.2×	97 0.2×	226 0.5×	101 0.3×	478 1.6×	38	1.7k
Susan Winandy United States	21	1.3k 1.7×	111 0.2×	475 1.0×	144 0.5×	660 2.1×	29	3.1k

Countries citing papers authored by Barbara Meissner

Since Specialization

Citations

This map shows the geographic impact of Barbara Meissner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Meissner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Meissner more than expected).

Fields of papers citing papers by Barbara Meissner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Meissner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Meissner. The network helps show where Barbara Meissner may publish in the future.

Co-authorship network of co-authors of Barbara Meissner

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Meissner. A scholar is included among the top collaborators of Barbara Meissner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Meissner. Barbara Meissner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alduaij, Waleed, Laurie H. Sehn, Brett Collinge, et al.. (2025). Population-wide introduction of dose-adjusted EPOCH-R in high-grade B-cell lymphoma with MYC / BCL2 rearrangements, DLBCL morphology. Blood Advances. 10(2). 320–333.

Bridgers, Joshua, Shujun Huang, Barbara Meissner, et al.. (2024). Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing. Clinical Chemistry. 70(1). 273–284. 2 indexed citations

Hilton, Laura K., Jeffrey Tang, Susana Ben‐Neriah, et al.. (2019). The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 134(18). 1528–1532. 76 indexed citations

Ricklefs, Franz, Beate Winkler, Barbara Meissner, et al.. (2019). Relapse of a group 4 medulloblastoma after 18 years as proven by histology and DNA methylation profiling. Child s Nervous System. 35(6). 1029–1033. 1 indexed citations

Hilton, Laura K., Miguel Alcaide, Aixiang Jiang, et al.. (2019). CRYPTIC MYC AND BCL2 REARRANGEMENTS ARE AMONG A RANGE OF GENETIC MECHANISMS UNDERLYING THE DOUBLE HIT SIGNATURE IN NON‐DOUBLE HIT DIFFUSE LARGE B‐CELL LYMPHOMA. Hematological Oncology. 37(S2). 73–74. 1 indexed citations

Hung, Stacy, Barbara Meissner, Elizabeth A. Chavez, et al.. (2018). Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management. Journal of Molecular Diagnostics. 20(2). 203–214. 53 indexed citations

Collinge, Brett, Lauren C. Chong, Susana Ben‐Neriah, et al.. (2017). Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism. Blood. 130. 3994–3994. 1 indexed citations

Meissner, Barbara, Martin Muik, Christoph Schwarzer, et al.. (2013). Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(6). 1421–1433. 11 indexed citations

Mejstříková, Ester, Petra Dörge, Barbara Meissner, et al.. (2012). Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL‐negative acute lymphoblastic leukemia. Pediatric Blood & Cancer. 60(3). 420–427. 19 indexed citations

10.

Lauten, Melchior, Anja Möricke, Rita Beier, et al.. (2012). Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica. 97(7). 1048–1056. 49 indexed citations

11.

Meissner, Barbara, T M Rogalski, Adam Warner, et al.. (2011). Determining the Sub-Cellular Localization of Proteins within Caenorhabditis elegans Body Wall Muscle. PLoS ONE. 6(5). e19937–e19937. 37 indexed citations

12.

Scott, David W., Fong Chun Chan, Fangxin Hong, et al.. (2011). A Gene Expression Signature in Diagnostic Formalin Fixed Paraffin Embedded Tissue Predicts Overall Survival in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma – a Correlative Study From the E2496 Intergroup Trial. Blood. 118(21). 430–430. 2 indexed citations

13.

Yap, Damian, Justin Chu, Tobias Berg, et al.. (2010). Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood. 117(8). 2451–2459. 435 indexed citations

14.

Meissner, Barbara, Adam Warner, Kim Wong, et al.. (2009). An Integrated Strategy to Study Muscle Development and Myofilament Structure in Caenorhabditis elegans. PLoS Genetics. 5(6). e1000537–e1000537. 85 indexed citations

15.

Mattner, Frauke, Karl‐Walter Sykora, Barbara Meissner, & Albert Heim. (2008). An Adenovirus Type F41 Outbreak in a Pediatric Bone Marrow Transplant Unit. The Pediatric Infectious Disease Journal. 27(5). 419–424. 32 indexed citations

16.

Sauer, Martin G., Barbara Meissner, Bernd Gruhn, et al.. (2008). Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005. Bone Marrow Transplantation. 43(5). 375–381. 15 indexed citations

17.

Meissner, Barbara, Arndt Borkhardt, Dagmar Dilloo, et al.. (2007). Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Bone Marrow Transplantation. 40(10). 945–949. 24 indexed citations

18.

Sauer, Martin G., Cornelia Zeidler, Barbara Meissner, et al.. (2007). Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman–Diamond syndrome. Bone Marrow Transplantation. 39(3). 143–147. 31 indexed citations

19.

Meissner, Barbara, Michael Boll, Hannelore Daniel, & Ralf Baumeister. (2004). Deletion of the Intestinal Peptide Transporter Affects Insulin and TOR Signaling in Caenorhabditis elegans. Journal of Biological Chemistry. 279(35). 36739–36745. 149 indexed citations

20.

Wenzel, Uwe, et al.. (2001). PEPT1-mediated uptake of dipeptides enhances the intestinal absorption of amino acids via transport system b0,+. Journal of Cellular Physiology. 186(2). 251–259. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact